Amyloid-β oligomers are inefficiently measured by enzyme-linked immunosorbent assay

Annals of Neurology

Volumn 58, Issue 1, 2005, Pages 147-150

  Stenh, Charlotte ^a   Englund, Hillevi ^a   Lord, Anna ^a   Johansson, Ann Sofi ^a   Almeida, Claudia G ^b   Gellerfors, Pär ^a   Greengard, Paul ^c   Gouras, Gunnar K ^b   Lannfelt, Lars ^a   Nilsson, Lars N G ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; OLIGOMER; SYNTHETIC PEPTIDE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DENATURATION; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BLOTTING, WESTERN; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; TRANSFECTION;

EID: 21844448609     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20524     Document Type: Article

References (17)

1. Jensen M, Schroder J, Blomberg M, et al. Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression. Ann Neurol 1999;45:504-511.
2. Motter R, Vigo-Peifrey C, Kholodenko D, et al. Reduction of beta-amyloid peptide42 in the cecebrospinal fluid of patients with Alzheimer's disease. Ann Neurol 1995;38:643-648.
3. Scheuner D, Eckman C, Jensen M, et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 1996;2:864-870.
4. Lambert MP, Barlow AK, Chromy BA, et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 1998;95:6448-6453.
5. Harper JD, Wong SS, Lieber CM, Lansbury PT. Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem Biol 1997;4:119-125.
6. Walsh DM, Lomakin A, Benedek GB, et al. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem 1997;272:22364-22372.
7. Gong Y, Chang L, Viola KL, et al. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci USA 2003;100:10417-10422.
8. Hoshi M, Sato M, Matsumoto S, et al. Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta. Proc Natl Acad Sci USA 2003;100:6370-6375.
9. Walsh DM, Hartley DM, Kusumoto Y, et al. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem 1999;274:25945-25952.
10. Kayed R, Head E, Thompson JL, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003;300:486-489.
11. Roher AE, Baudry J, Chaney MO, et al. Oligomerization and fibril assembly of the amyloid-beta protein. Biochim Biophys Acta 2000;1502:31-43.
12. Kuo YM, Emmerling MR, Lampert HC, et al. High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease. Biochem Biophys Res Commun 1999;257:787-791.
13. Nilsberth C, Westlind-Danielsson A, Eckman CB, et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat Neurosci 2001;4:887-893.
14. Stenh C, Nilsberth C, Hammarbäck J, et al. The Arctic mutation interferes with processing of the amyloid precursor protein. Neuroreport 2002;13:1857-1860.
15. Cheng IH, Palop JJ, Esposito LA, et al. Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation. Nat Med 2004;10:1190-1192.
16. Mullan M, Ctawford F, Axelman K, et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1992;1:345-347.
17. Lord A, Kalimo H, Eckman C, et al. The Arctic Alzheimer mutation facilitates early intraneuronal Aβ aggregation and senile plaque formation in transgenic mice. Neurobiol Aging (published online Feb 17, 2005).